Literature DB >> 2434124

HLA-DR antigen expression on keratinocytes in highly inflamed parts of psoriatic lesions.

T Terui, S Aiba, T Kato, T Tanaka, H Tagami.   

Abstract

We have investigated the immunoperoxidase staining pattern in the epidermis and dermal infiltrates of highly inflamed portions of psoriatic lesions, selecting for biopsy early pinpoint lesions or margins of active plaque lesions. We found positive intercellular staining for HLA-DR antigens in localized areas of the epidermis in about half of the patients tested. In contrast, OKT6 antigen was found only on the dendritic cells in the epidermis and dermis in all cases. These findings support the hypothesis that an active cellular immune reaction involving the epidermis, possibly associated with the expression of HLA-DR antigens on keratinocytes, occurs in the highly inflamed areas of psoriatic lesions, particularly in early pinpoint lesions or at the edges of spreading plaque lesions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2434124     DOI: 10.1111/j.1365-2133.1987.tb05794.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  12 in total

1.  Soluble interleukin-2 receptors and psoriasis.

Authors:  R Dummer; F G Dunkel
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

2.  Epidermal Langerhans cells, dermal dendritic cells, and keratinocytes in viral lesions of skin and mucous membranes: an immunohistochemical study.

Authors:  M Drijkoningen; C De Wolf-Peeters; H Degreef; V Desmet
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

3.  Dermal injection of immunocytes induces psoriasis.

Authors:  T Wrone-Smith; B J Nickoloff
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

4.  Interleukin 2, soluble interleukin 2 receptor, and interferon-gamma in the suction blister fluids from psoriatic skin.

Authors:  H Takematsu; H Tagami
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

5.  Histopathological and immunohistochemical changes in psoriatic skin during peptide T treatment.

Authors:  T Talme; B L Rozell; K G Sundqvist; L Wetterberg; J A Marcusson
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

6.  Proliferative responses of peripheral blood mononuclear cells from psoriatic patients to T lymphocyte-stimulating cytokines (IL-2, IL-3, IL-4, and granulocyte-macrophage colony-stimulating factor) and OK-432.

Authors:  S Aiba; H Tagami
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

7.  Adhesion molecule expression in psoriatic skin lesions and the influence of cyclosporin A.

Authors:  C Horrocks; J I Duncan; A M Oliver; A W Thomson
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

8.  CCN1, a Pro-Inflammatory Factor, Aggravates Psoriasis Skin Lesions by Promoting Keratinocyte Activation.

Authors:  Yue Sun; Jie Zhang; Zhou Zhou; Pinru Wu; Rongfen Huo; Beiqing Wang; Zhengyu Shen; Huidan Li; Tianhang Zhai; Baihua Shen; Xiangdong Chen; Ningli Li
Journal:  J Invest Dermatol       Date:  2015-06-22       Impact factor: 8.551

Review 9.  The role of complement-derived mediators in inflammatory skin diseases.

Authors:  H Tagami
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

10.  In situ localization of interferons in psoriatic lesions.

Authors:  J K Livden; R Nilsen; J R Bjerke; R Matre
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.